関連する実験動画
Updated: Jun 11, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
メタスタシス制御のためのマイクロRNAターゲティングダイサー
Graziano Martello1, Antonio Rosato, Francesco Ferrari
1Department of Histology, Microbiology and Medical Biotechnologies, University of Padua School of Medicine, viale Colombo 3, 35126 Padua, Italy.
Cell
|July 7, 2010
まとめ
高レベルのマイクロRNA (miRNA),特にmiR-103/107は,Dicerを標的とし,上皮からメゼンキマへの移行 (EMT) を誘導することによって,癌の転移を促進します. これらのmiRNAを阻害すると,がん細胞の移動と拡散を減らすことができます.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 遺伝子規制 遺伝子規制
背景:
- グローバルマイクロRNA (miRNA) のダウンレギュレーションは,ヒトの癌ではよく見られるが,そのメカニズムと効果は不明である.
- マイクロRNAは遺伝子発現を調節し,がんの発達と進行において極めて重要です.
研究 の 目的:
- がんにおける世界的なmiRNAダウンレギュレーションに関与するmiRNAを特定する.
- 癌の転移および上皮からメゼンキマへの移行 (EMT) に関するmiR-103/107の役割を調査する.
主な方法:
- miRNAバイオシンセシスの重要な酵素であるDicerを標的とするmiR-103/107の識別.
- 人間の乳がん組織におけるmiR-103/107濃度の分析.
- 細胞の移動と転移に対するmiR-103/107の機能的影響を評価するためのインビトロおよびインビボ実験.
- miR-103/107がmiR-200レベルとEMT誘導に及ぼす影響の調査.
主要な成果:
- miR-103/107はDicerを直接標的にして弱め,全体的なmiRNAバイオシンセシスを減少させます.
- 高濃度のmiR-103/107は,乳がん患者の転移と不良予後と相関しています.
- miR-103/107の過剰発現は,がん細胞の移動をインビトロで促進し,インビヴォでは転移を促進する.
- miR-103/107の抑制は,がん細胞の移動と転移を抑制する.
- miR-103/107は,miR-200ファミリーメンバーをダウンレギュレーションすることによってEMTを誘発します.
結論:
- miR-103/107ファミリーは,Dicer阻害とEMT誘導を通じてがん転移を促進する上で重要な役割を果たしています.
- ターゲティング miR-103/107は,がんの転移と闘うための潜在的な治療戦略を提供します.
- この研究は,miRNAの調節不良を癌の進行と侵襲性に関連付ける新しいメカニズムを明らかにしています.
関連する概念動画
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
